PNC FINANCIAL SERVICES GROUP, INC.
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 713676
Pittsburgh, PA
Position in TAK
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,050,339
+$132,373 QoQ
Shares Held
56,714
-3.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96.04506823711958.ToString("F0")%
Shared 3.9549317628804177.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $46,500,192 across 42 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
203,999 | $24,114,720 | |
| 2 | VTRS |
Viatris Inc
|
475,726 | $6,427,053 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
95,610 | $2,879,772 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,397 | $2,607,330 | |
| 5 | HLN |
Haleon plc
|
249,107 | $2,493,559 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
99,650 | $1,380,152 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
56,714 | $1,050,339 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
14,548 | $751,984 |
All Filings in TAK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,050,339 | 56,714 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $917,966 | 58,882 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $1,076,769 | 73,550 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,068,498 | 69,114 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $870,933 | 58,570 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $777,304 | 58,709 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $786,605 | 55,317 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $713,520 | 55,141 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $952,294 | 68,560 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,023,613 | 71,732 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $5,060,480 | 327,116 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,204,155 | 331,264 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,745,518 | 348,636 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,549,244 | 355,721 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $4,753,593 | 366,507 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,762,658 | 339,221 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,318,386 | 371,396 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,475,317 | 401,711 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,372,864 | 450,114 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $7,542,294 | 448,146 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $7,984,347 | 437,259 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $8,057,338 | 442,711 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,905,791 | 443,150 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $8,468,478 | 472,308 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $8,397,208 | 553,176 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||